EMA finds ‘possible link’ between rare blood clots and Johnson & Johnson vaccine
Share article:
Share article:

EMA finds ‘possible link’ between rare blood clots and Johnson & Johnson vaccine

Credit: Belga

A possible link between Johnson & Johnson’s coronavirus vaccine and very rare cases of unusual blood clots with low blood platelets has been found, the European Medicines Agency (EMA) announced on Tuesday.

EMA’s safety committee (PRAC) concluded that a warning about unusual blood clots with low blood platelets should be added to the product information for the company’s Covid-19 vaccine, and that they should be listed as “very rare side effects” of the vaccine.

However, EMA also confirmed that the overall benefit-risk analysis remains positive, and the benefits of preventing Covid-19 outweigh the risk of side effects.

While the Agency is not recommending any steps to limit the vaccine’s use, it urges healthcare professionals as well as people who will receive the vaccine to be aware of the possibility of this side effect occurring within three weeks of vaccination.

Related News:


To reach this conclusion, the PRAC considered all currently available evidence, including eight reports of serious cases of unusual blood clots associated with low levels of blood platelets, one of which had a fatal outcome, in the United States, where over 7 million people received the vaccine as of 13 April 2021.

All cases occurred in people under 60 years old within three weeks after vaccination, the majority of which were women.

Based on the currently available evidence, however, specific risk factors have not been confirmed, according to EMA.

Additionally, the PRAC also noted that the blood clots mainly occurred at “unusual sites” such as in veins in the brain (cerebral venous sinus thrombosis, or CVST), the abdomen (splanchnic vein thrombosis) and in arteries, together with low levels of blood platelets and sometimes bleeding.

The cases reviewed were very similar to the cases that occurred with AstraZeneca’s Covid-19 vaccine, according to EMA.

One plausible explanation for the combination of blood clots and low blood platelets is an immune response, leading to a condition similar to one seen sometimes in patients treated with heparin, called heparin-induced thrombocytopenia (HIT).

Maïthé Chini
The Brussels Times

Latest news

More than one billion coronavirus vaccines exported by EU
The European Union (EU) has exported more than one billion coronavirus vaccines globally over the past ten months, of which just under one-tenth was ...
SNCB brings free little libraries to stations
The Belgian railway company SNCB is adding free little libraries to its stations. The “book boxes,” as they’re called, allow passengers to grab a ...
Belgium in Brief: What Is Bouncing Back?
What do you think of when you think of a country "bouncing back" after a crisis?  Cambridge Dictionary says it is "to start to be successful again ...
Café patron stabs manager after being asked to see proof of vaccination
A customer stabbed a café manager in Brussels on Saturday after being asked to show his Covid Safe Ticket (CST), according to Bruzz. Asking to see ...
Belgium to simplify administrative processes with ‘digital wallet’
The federal government wants to create an online "wallet" for all people living in Belgium which would bundle all official documents, from visas to ...
‘Start of infection wave’: Flanders to turn red on European map again
Flanders will turn red on the map of the European Centre for Disease Prevention and Control (ECDC) again this week, as the daily average of new ...
Staff strike at application centre for asylum seekers
The staff of an application centre for asylum seekers in Brussels began a 24-strike on Monday morning, meaning that no one can apply for asylum there ...
Bpost plans to merge parcel and letter services in Belgium
The new CEO of Bpost – Belgium's primary mail delivery company and one of the country's largest civilian employers – has decided to merge the ...
Belgian playground bullying drama wins at London Film Festival
Playground (original title 'Un Monde'), the first feature film by Belgian director Laura Wandel, was awarded the top prize in the First Feature ...
Brussels launches initiatives to improve cyclist and pedestrian safety
Two new initiatives are being developed in Brussels to make the city safer and more pedestrian and cyclist-friendly, especially around key areas on ...
Vaccination coverage in Wallonia breaks 70 percent
The Wallonia Region in Belgium has reached the milestone of having 70 percent of its population receive at least one shot of a Covid-19 vaccine, ...
Belgian youth asked to skip school for Friday’s climate strike
Young people in Belgium have been called on by the climate movement Youth for Climate to once again skip school and take to the streets during the ...